Thomas Berger

Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

Detlef Dieckmann, Heidi Plöttner, Susanne Berchtold et al. · The Journal of Experimental Medicine · 2001 · 1.1K citations · Full text

Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells

Beatrice Schuler‐Thurner, Erwin Schultz, Thomas Berger et al. · The Journal of Experimental Medicine · 2002 · 476 citations · Full text

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Dirk Schadendorf, Selma Ugurel, Beatrice Schuler‐Thurner et al. · Annals of Oncology · 2006 · 466 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +9

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michele Maio, Karl D. Lewis, Lev Demidov et al. · The Lancet Oncology · 2018 · 210 citations · Full text

Medicine, Melanoma, Immunology +10

Artesunate in the treatment of metastatic uveal melanoma - first experiences

Thomas Berger, Detlef Dieckmann, Thomas Efferth et al. · Oncology Reports · 2005 · 176 citations